Lips et al. calculated a 1.2 difference in CPD due to the fact that rs16969968 homozygotes in CHRNA5 only contribute a 9% increase in lung cancer risk, which cannot account for the association between the variants, smoking behavior and lung cancer[31]. This evidence concerns the gene CHRNA5 and lung cancer.